We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
726
DELISTED
Synovus
SNV
| $6.29M | 0.01% |
128,254
+2,673
| +2% | +$135K |
|
727
United Natural Foods
UNFI
$2.79B
| $6.21M | 0.01% |
150,319
+8,931
| +6% | +$365K |
|
728
Pacira BioSciences
PCRX
$993M
| $6.18M | 0.01% |
80,942
-302
| -0.4% | -$20.1K |
|
729
Newmark Group
NMRK
$2.57B
| $6.12M | 0.01% |
384,564
+131,592
| +52% | +$2.14M |
|
730
Yext
YEXT
$632M
| $6.11M | 0.01% |
886,320
+886,319
| +88,631,900% | +$6.76M |
|
731
Vanda Pharmaceuticals
VNDA
$302M
| $6.09M | 0.01% |
538,542
-4,122
| -0.8% | -$54.2K |
|
|
HSII
732
DELISTED
Heidrick & Struggles
HSII
| $6.08M | 0.01% |
153,481
| – | – |
|
733
Warrior Met Coal
HCC
$4.9B
| $5.98M | 0.01% |
+161,113
| New | +$5.15M |
|
|
CWEN.A
734
DELISTED
Clearway Energy Class A
CWEN.A
| $5.93M | 0.01% |
177,996
-1,201
| -0.7% | -$37.5K |
|
|
ORTX
735
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $5.92M | 0.01% |
830,986
| – | – |
|
|
SEM
736
DELISTED
Select Medical
SEM
| $5.9M | 0.01% |
456,797
-193,276
| -30% | -$2.55M |
|
|
TWNK
737
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $5.9M | 0.01% |
269,033
+176,804
| +192% | +$3.67M |
|
738
Intel
INTC
$534B
| $5.9M | 0.01% |
119,056
-151,490
| -56% | -$7.51M |
|
|
RYZ
739
Ryerson Holding Corp
RYZ
$1.26B
| $5.86M | 0.01% |
167,190
+1,179
| +0.7% | +$32.1K |
|
740
Sempra
SRE
$53.4B
| $5.82M | 0.01% |
69,274
-22,460
| -24% | -$1.61M |
|
741
Charter Communications
CHTR
$16.1B
| $5.8M | 0.01% |
10,642
-13,937
| -57% | -$8.18M |
|
742
Guardant Health
GH
$23.5B
| $5.78M | 0.01% |
87,300
-12,700
| -13% | -$869K |
|
743
Gibraltar Industries
ROCK
$1.33B
| $5.78M | 0.01% |
+134,509
| New | +$7.09M |
|
744
1stdibs.com
DIBS
$145M
| $5.77M | 0.01% |
722,658
| – | – |
|
745
LeMaitre Vascular
LMAT
$1.84B
| $5.77M | 0.01% |
124,168
-5,568
| -4% | -$249K |
|
746
Ryder
R
$9.13B
| $5.76M | 0.01% |
72,593
+1,177
| +2% | +$91.6K |
|
747
Torrid Holdings
CURV
$214M
| $5.76M | 0.01% |
950,000
| – | – |
|
748
BorgWarner
BWA
$12.7B
| $5.72M | 0.01% |
167,091
-101
| -0.1% | -$3.77K |
|
749
Williams-Sonoma
WSM
$25.7B
| $5.72M | 0.01% |
78,912
+5,194
| +7% | +$393K |
|
750
Boyd Gaming
BYD
$5.49B
| $5.63M | 0.01% |
85,661
-44,888
| -34% | -$2.92M |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.